Single‐dose therapy for lupus nephritis: C‐reactive protein, nature's own dual scavenger and immunosuppressant
Open Access
- 3 February 2005
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (2) , 378-381
- https://doi.org/10.1002/art.20847
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Reversal of ongoing proteinuria in autoimmune mice by treatment with C‐reactive proteinArthritis & Rheumatism, 2005
- Autoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient MiceScience, 2004
- Interleukin-10andRelatedCytokines andReceptorsAnnual Review of Immunology, 2004
- Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C‐reactive protein transgeneArthritis & Rheumatism, 2003
- IL-10 Regulates Murine LupusThe Journal of Immunology, 2002
- Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunityNature Medicine, 1999
- Immunosuppressive effects of apoptotic cellsNature, 1997
- The interaction of C-reactive protein and serum amyloid P component with nuclear antigensMolecular Biology Reports, 1996
- Structure and function of the pentraxinsCurrent Opinion in Immunology, 1995
- Decreased Autoantibody Levels and Enhanced Survival of (NZB × NZW) F1 Mice Treated with C-Reactive ProteinClinical Immunology and Immunopathology, 1994